Glutaurine compositions and therapeutic uses thereof

Abstract

The present disclosure provides compositions and methods useful for the treatment of a body weight condition or a thyroid disorder. The compositions induces increased T3 levels while preventing thyroidal atrophy. Also provided are compositions and methods for the treatment of a disease or condition that is estrogen sensitive, estrogen receptor dependent or estrogen receptor mediated such as breast cancer.

What is claimed is: 
     
       1. A method of regulating body weight comprising administering about 500-1000 mcg per day of glutaurine to an obese human subject. 
     
     
       2. The method of  claim 1 , wherein administration of glutaurine increases levels of triiodothyronine (T3) in the subject while preventing thyroidal atrophy. 
     
     
       3. The method of  claim 1 , wherein the obese human subject is in need of inducing fat loss, preventing fat gain, and/or increasing metabolic consumption of adipose tissue to treat obesity. 
     
     
       4. The method of  claim 1 , wherein administration of glutaurine maintains muscle mass and/or induces an increase in muscle mass. 
     
     
       5. The method of  claim 1 , wherein the glutaurine is incorporated into a nutritional or dietary supplement. 
     
     
       6. The method of  claim 1 , wherein glutaurine is formulated in an orally administrable form selected from the group consisting of a tablet, a powder, a gel capsule, and a liquid. 
     
     
       7. The method of  claim 1 , wherein the glutaurine is administered in an amount effective for inducing fat loss, preventing fat gain, and/or increasing the metabolic consumption of adipose tissue in the obese human subject.